Fortfahren mit
Spend € 450 — Save 5 %; Spend € 700 — Save 10 %; Spend € 1.500 — Save 15 %*
Anmelden zur Überprüfung der Spielberechtigung. Produkte kaufen
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|---|---|
100 mg | Warenkorb auf Verfügbarkeit prüfen | € 1.310,00 |
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
carteolol
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
Cl.N(C(C)(C)C)CC(O)COc1c2c(nc(cc2)O)ccc1
InChI
1S/C16H22N2O3.ClH/c1-16(2,3)17-9-11(19)10-21-14-6-4-5-13-12(14)7-8-15(20)18-13;/h4-8,11,17,19H,9-10H2,1-3H3,(H,18,20);1H
InChI key
AQKPYMCBUMYZNK-UHFFFAOYSA-N
General description
For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description United States Pharmacopeia (USP) Reference Standard | description United States Pharmacopeia (USP) Reference Standard | description United States Pharmacopeia (USP) Reference Standard | description United States Pharmacopeia (USP) Reference Standard |
| grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade pharmaceutical primary standard |
| manufacturer/tradename USP | manufacturer/tradename USP | manufacturer/tradename USP | manufacturer/tradename USP |
| application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) |
| format neat | format neat | format neat | format neat |
| API family carteolol | API family moexipril | API family levobunolol | API family dopamine |
| agency USP | agency USP | agency USP | agency USP |
Lagerklasse
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.


